Speeding Time to Therapy
on present-day ePA and the future
Creating value in today's
by Tony Schueth, CEO & Managing Partner
A growing number of medications require prior authorization (PA) before they can be dispensed. This is a concern among providers, who are very troubled about the impacts. And they can be detrimental to patients’ health. A recent survey by the American Medical Association (AMA) found that more than 9 in 10 physicians (91%) said that the prior authorization process delays patient access to necessary care. Three-quarters (75%) report that prior authorization leads to patients abandoning a recommended course of treatment. A similar percentage found that PA processes cause adverse events.
These disturbing findings are the latest in a litany of problems that have long been associated with today’s costly and antiquated PA processes. In response, the industry will be doubling down this year on electronic processes to streamline PAs and benefit checks for drugs covered under the patient’s pharmacy benefit as well as those covered under the patient’s medical benefit. This will make PA submissions and responses for drugs faster and easier, prevent delays in treatment and find affordable therapies.
This is where we see accelerated activities around ePA:
The Point-of-Care Partners team is actively engaged in a wide range of activities related to the development and adoption of ePA. Want to know more or become involved? Reach out to me at firstname.lastname@example.org.
In this video, Tony provides insights about some of the company’s 2018 health IT predictions and why he thinks electronic prior authorization will be front and center in 2019.